Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT)

NCT00742794 | Completed DMC

• 1 other identifier: ZU-HVA-001
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy

Conditions

Hymenoptera Sting Allergy

Study Arms (1)

1

Hymenoptera sting allergic patients under immunotherapy

Other: Observation

Interventions

Observation OTHER

Observation of sting frequency

1

Eligibility Criteria

• Age: 5 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Hymenoptera sting allergic patients under allergen specific immunotherapy

You may qualify if:

• Bee and/or Wasp allergic patients treated by SIT

You may not qualify if:

• None

Sponsors & Collaborators

• University of Zurich: lead

Study Sites (1)

Unknown Facility

Zurich, Switzerland

Location

MeSH Terms

Interventions

Observation

Intervention Hierarchy (Ancestors)

Methods; Investigative Techniques

Study Officials

• 01 Studienregister MasterAdmins

  UniversitaetsSpital Zuerich

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: August 27, 2008
• First Posted: August 28, 2008
• Study Start: August 1, 2008
• Study Completion: August 1, 2010
• Last Updated: August 19, 2010

Record last verified: 2008-09

Locations

CH (1)